- Home
- JSPR
as 07-26-2024 4:00pm EST
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
| Founded: | 2018 | Country: | United States |
| Employees: | N/A | City: | REDWOOD CITY |
| Market Cap: | 349.8M | IPO Year: | N/A |
| Target Price: | $70.75 | AVG Volume (30 days): | 265.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 10 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -5.61 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.00 - $31.01 | Next Earning Date: | 08-09-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Jasper Therapeutics Inc. News
JSPR Breaking Stock News: Dive into JSPR Ticker-Specific Updates for Smart Investing
GlobeNewswire
a month ago
Jasper Therapeutics Announces Appointment of Svetlana Lucas Ph.D., to its Board of Directors
GlobeNewswire
a month ago
Jasper Therapeutics to Present at the Oppenheimer Novel Targets in Immunology Summit
GlobeNewswire
a month ago
Jasper Therapeutics Presents Data from Preclinical Briquilimab Study at the 2024 EHA Hybrid Congress
GuruFocus.com
2 months ago
Catherine Wood's Strategic Acquisition of PagerDuty Inc Shares
GuruFocus.com
2 months ago
Insider Sale at Cogent Communications Holdings Inc (CCOI): CFO Thaddeus Weed Sells 2,400 Shares
CNW Group
2 months ago
Gluckstein Lawyers Involved in Landmark Ruling Against Ukraine International Airlines in Flight PS 752 Case
Yahoo Finance Video
2 months ago
FDA panel votes to recommend Eli Lilly's Alzheimer's drug
GlobeNewswire
2 months ago
Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis
Compare JSPR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "JSPR Jasper Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.